نتایج جستجو برای: cns relapse prophylaxis

تعداد نتایج: 167473  

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006
Julio C Barredo Meenakshi Devidas Stephen J Lauer Amy Billett Maryanne Marymont Jeanette Pullen Bruce Camitta Naomi Winick William Carroll A Kim Ritchey

PURPOSE Prognosis and outcome of children with isolated CNS relapse of acute lymphoblastic leukemia (ALL) has depended on duration of first complete remission (CR1). This study intensified systemic therapy by delaying CNS radiation for 12 months and tailored CNS radiation by CR1 duration. PATIENTS AND METHODS Seventy-six children with first isolated CNS relapse of ALL were treated with system...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2006
F Lokiec

The incidence of central nervous system (CNS) recurrence in patients with lymphoma is about 5%. Nevertheless, this complication is very serious because it is almost always fatal. Its incidence is not sufficiently high to warrant the use of CNS prophylaxis in all patients. The identification of subgroups for whom CNS prophylaxis may be of benefit is therefore important and the age-adjusted inter...

Journal: :Blood 2009
Sanjay Swaminathan John Zaunders John Wilkinson Kazuo Suzuki Anthony D Kelleher

The patient succumbed to CNS disease 3 months afterward, despite CNS-directed chemotherapy. Sequencing of the BCR-ABL kinase domain from BM blasts, at the time of BC, and CSF tumor cells, at CNS relapse, did not show any mutation. The lack of BM blastosis, the reduced marrow BCR-ABL levels and the absence of a mutated clone, in BM and CSF, at the onset of meningeal leukemia, indicate that syste...

Journal: :British journal of haematology 2005
Andrew McMillan

All adult patients with Burkitt lymphoma or lymphoblastic lymphoma should receive central nervous system (CNS)-directed therapy with both intrathecal and high-dose systemic chemotherapy. There is no evidence to support the routine use of prophylactic CNS-directed therapy in any specific subgroup of adult patients with 'low grade' lymphomas. There are some anatomical sites where involvement by l...

2014
Ashish Narayan Masurekar Catriona A. Parker Milensu Shanyinde Anthony V. Moorman Jeremy P. Hancock Rosemary Sutton Philip J. Ancliff Mary Morgan Nicholas J. Goulden Chris Fraser Peter M. Hoogerbrugge Tamas Revesz Philip J. Darbyshire Shekhar Krishnan Sharon B. Love Vaskar Saha Maria R. Baer

UNLABELLED The outcomes of Central Nervous System (CNS) relapses in children with acute lymphoblastic leukaemia (ALL) treated in the ALL R3 trial, between January 2003 and March 2011 were analysed. Patients were risk stratified, to receive a matched donor allogeneic transplant or fractionated cranial irradiation with continued treatment for two years. A randomisation of Idarubicin with Mitoxant...

Journal: :Journal of immunology 2012
Wakiro Sato Atsuko Tomita Daijyu Ichikawa Youwei Lin Hitaru Kishida Sachiko Miyake Masafumi Ogawa Tomoko Okamoto Miho Murata Yoshiyuki Kuroiwa Toshimasa Aranami Takashi Yamamura

Multiple sclerosis (MS) is a demyelinating disease of the CNS that is presumably mediated by CD4(+) autoimmune T cells. Although both Th1 and Th17 cells have the potential to cause inflammatory CNS pathology in rodents, the identity of pathogenic T cells remains unclear in human MS. Given that each Th cell subset preferentially expresses specific chemokine receptors, we were interested to know ...

Journal: :Blood 1991
G Henze R Fengler R Hartmann B Kornhuber G Janka-Schaub D Niethammer H Riehm

Between April 1985 and March 1987 130 children and adolescents up to 18 years of age with first relapse of acute lymphoblastic leukemia (ALL) were registered on the stratified and randomized multicentric trial ALL-REZ BFM 85 designed for patients pretreated with intensive front-line therapies. Stratification criteria were time and site of relapse: bone marrow (BM) relapse on or up to 6 months a...

Journal: :Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016
Kirsten Lindner Christoph Anthoni Susanne Beckebaum Norbert Senninger Jens Peter Hölzen Heiner Wolters

OBJECTIVES Cytomegalovirus infections cause the most frequent infection after solid-organ transplant. While Cytomegalovirus prophylaxis is established in high-risk patients (donor+/ recipient-), data on Cytomegalovirus prophylaxis in other serostatus constellation are rare. The aim of this study was to evaluate the influence of Cytomegalovirus treatment strategy after a liver transplant (preemp...

2015
Christian W. Eskelund Niels Frost Andersen

Primary plasma cell leukaemia (pPCL) is a rare and aggressive form of plasma cell malignancies with a very poor prognosis. Compared to other plasma cell malignancies the tendency to extramedullary spread is increased; however central nervous system (CNS) involvement is rare and only reported in few cases. We report the case of a 61-year-old man who was diagnosed with pPCL and achieved a complet...

ژورنال: یافته 2012
شاهسوار, فرهاد, آذرگون, علیرضا , سابوته, توماج , علی‌مقدم, کامران , نظرزاده, سارا ,

Background : Graft versus host disease (GVHD) is among major complications of allogeneic hematopoietic stem cells transplantation, and also is an important factor affecting the outcome of transplantation. An increased incidence of GVHD has been suggested following allogeneic peripheral blood stem cells (PBSC) transplantation, however, how this affects survival is not yet well clear. In this stu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید